{"lc": {"ivermectin-can-kill-covid-19-within-48-hours-monash-university-study-finds": {"story_link": "https://www.thepharmaletter.com/article/ivermectin-can-kill-covid-19-within-48-hours-monash-university-study-finds", "user_code": "GOLD_2", "age_group": "21_30", "agreed": true, "close_date_time": "2021-10-15 13:19:31", "close_timestamp": 1636982371113, "created": "15/11/2021 13:19:28", "department": "Computing", "disability": false, "ease": 4, "environment": "production", "experiment_date_datepicker": "2021-11-15", "gender": "female", "id": "887f855a-08ac-40e4-9f2d-134c472520ed", "open_date_time": "2021-10-15 13:12:56", "open_timestamp": 1636981976429, "story_date": "2020-04-21 00:00:00", "story_source": "tpl", "story_title": "Ivermectin can kill COVID-19 within 48 hours', Monash University study finds", "summary": "The story is about Dr Kylie Wagstaff research at Monash University. It concerns the use of Ivermectin against COVID-19 virus variants.", "task_condition": "viz", "task_key": "ivermectin-can-kill-covid-19-within-48-hours-monash-university-study-finds", "task_level": "post_graduate_ma_msc", "time_taken_in_seconds": 394684, "what": "Research about the effects of Ivermectin against the COVID-19 virus", "when_happened": "few_years_ago", "where_location": "Monash University", "who": "Dr Kylie Wagstaff, Ivermectin, Monash University", "why": "Combat the COVID-19 virus"}, "challenges-expected-for-novavax-covid-19-vaccine-in-usa": {"story_link": "https://www.thepharmaletter.com/article/challenges-expected-for-novavax-covid-19-vaccine-in-usa", "user_code": "GOLD_2", "age_group": "21_30", "agreed": true, "close_date_time": "2021-10-15 13:0:46", "close_timestamp": 1636981246131, "created": "15/11/2021 13:00:43", "department": "Computing", "disability": false, "ease": 4, "environment": "production", "experiment_date_datepicker": "2021-11-15", "gender": "female", "id": "227da79b-4adc-4005-840e-5c5ae8bd256e", "open_date_time": "2021-10-15 12:49:29", "open_timestamp": 1636980569304, "story_date": "2021-06-23 00:00:00", "story_source": "tpl", "story_title": "Challenges expected for Novavax' COVID-19 vaccine in USA", "summary": "The story is concerned with the vaccination rates with NVX-CoV2373 within the US and Mexico. It explains the observed efficiency of the vaccine on a global scale. The story gives a possible outlook into Novavax further plans of distributing the vaccine.", "task_condition": "text", "task_key": "challenges-expected-for-novavax-covid-19-vaccine-in-usa", "task_level": "post_graduate_ma_msc", "time_taken_in_seconds": 676827, "what": "COVID-19, Vaccination Rates, Vaccination Efficiency", "when_happened": "few_month_ago", "where_location": "US, Mexico, UK, South Africa", "who": "Novavax", "why": "Public Health, Pandemic Prevention"}, "australian-gps-urged-to-prescribe-ivermectin-triple-therapy-to-fight-covid-19": {"story_link": "https://www.thepharmaletter.com/article/australian-gps-urged-to-prescribe-ivermectin-triple-therapy-to-fight-covid-19", "user_code": "GOLD_2", "age_group": "21_30", "agreed": true, "close_date_time": "2021-10-15 13:25:19", "close_timestamp": 1636982719487, "created": "15/11/2021 13:25:16", "department": "Computing", "disability": false, "ease": 3, "environment": "production", "experiment_date_datepicker": "2021-11-15", "gender": "female", "id": "7117877b-1ca9-40a7-9a58-fc6c80b0abe3", "open_date_time": "2021-10-15 13:19:47", "open_timestamp": 1636982387626, "story_date": "2020-08-20 00:00:00", "story_source": "tpl", "story_title": "Australian GPs urged to prescribe ivermectin triple therapy to fight COVID-19", "summary": "The story talks about the efficiency of Ivermectin as a COVID-19 treatment. It also explains the discussion and disagreements between medical practitioners and other players on this topic.", "task_condition": "viz", "task_key": "australian-gps-urged-to-prescribe-ivermectin-triple-therapy-to-fight-covid-19", "task_level": "post_graduate_ma_msc", "time_taken_in_seconds": 331861, "what": "If Ivermectin should be prescribed as a treatment against COVID-19", "when_happened": "few_years_ago", "where_location": "Australia", "who": "Australian government, Australian GPs", "why": "It explores the possible uses of Ivermectin against its risks"}, "japan-is-first-country-to-approve-covid-19-cocktail-ronapreve": {"story_link": "https://www.thepharmaletter.com/article/japan-is-first-country-to-approve-covid-19-cocktail-ronapreve", "user_code": "GOLD_2", "age_group": "21_30", "agreed": true, "close_date_time": "2021-10-15 13:12:38", "close_timestamp": 1636981958277, "created": "15/11/2021 13:12:35", "department": "Computing", "disability": false, "ease": 3, "environment": "production", "experiment_date_datepicker": "2021-11-15", "gender": "female", "id": "c9f41e67-a646-4fca-b1c9-2f7c90931a0c", "open_date_time": "2021-10-15 13:1:0", "open_timestamp": 1636981260721, "story_date": "2020-07-21 00:00:00", "story_source": "tpl", "story_title": "Japan is first country to approve COVID-19 cocktail Ronapreve", "summary": "The story is about the approval of the antibody medicine Ronapreve in Japan and its emergency use within a variety of other countries. It also informs about a possible distribution of Ronapreve in the future.", "task_condition": "text", "task_key": "japan-is-first-country-to-approve-covid-19-cocktail-ronapreve", "task_level": "post_graduate_ma_msc", "time_taken_in_seconds": 697556, "what": "The approval of Ronapreve, The areas of its use", "when_happened": "few_years_ago", "where_location": "Japan", "who": "Roche, Japan's Ministry of Health Labor and Welfare, Chugai Pharmaceutical", "why": "It informs on a medicine that has shown to reduce strong symptoms and death in a variety of COVID-19 patients"}}, "tb": {"pfizer": {"story_term": "pfizer", "user_code": "GOLD_2", "age_group": "21_30", "agreed": true, "close_date_time": "2021-10-15 13:59:38", "close_timestamp": 1636984778569, "created": "15/11/2021 13:59:36", "department": "Computing", "disability": false, "ease": 3, "environment": "production", "experiment_date_datepicker": "2021-11-15", "gender": "female", "id": "b1ff3e31-c1ea-44fb-a378-6937e7300270", "open_date_time": "2021-10-15 13:25:29", "open_timestamp": 1636982729740, "summary": "Pfizer's vaccine has shown to be a effective measurement against the spread as well as the course of disease of COVID-19. The vaccine was approved by several global health institutions, such as Health Canada, US Centers for Disease Control and Prevention, US Food and Drug Administration.\r\n\r\nEven regarding the success rate of the vaccine, it should not be forgotten that this treatment is also a lucrative business for the pharma giant \u00e2\u0080\u0093 which can lead to situations that need our ethical consideration. During the last months for example, the vaccine was approved and even recommended for children in several western countries, while many regions of the global south still experience a shortage of dosses to protect high risk individuals. I agree here with Anna Marriott, health policy manager at international development charity Oxfam, who said: \u00e2\u0080\u009cThis is a public health emergency, not a private profit opportunity. We should not be letting corporations decide who lives and who dies while boosting their profits. We need a people\u00e2\u0080\u0099s vaccine, not a profit vaccine.\"", "task_condition": "text", "task_key": "pfizer", "task_level": "post_graduate_ma_msc", "time_taken_in_seconds": 2048829}, "astrazeneca": {"story_term": "astrazeneca", "user_code": "GOLD_2", "age_group": "21_30", "agreed": true, "close_date_time": "2021-10-15 14:31:30", "close_timestamp": 1636986690401, "created": "15/11/2021 14:31:32", "department": "Computing", "disability": false, "ease": 5, "environment": "production", "experiment_date_datepicker": "2021-11-15", "gender": "female", "id": "f9f7bacb-e777-4cf6-a050-4534aec67b54", "open_date_time": "2021-10-15 13:59:46", "open_timestamp": 1636984786953, "summary": "Together with Pfizer, Astrazeca is one of the biggest producers of COVID-19 vaccines. The company has started a massive global rollout of doses after studies confirmed its effectivity. The vaccine has soon been linked to a rare complication where blood cloths can form \u00e2\u0080\u0093 possibly leading to a patients death.\r\n\r\nEven after several confirmed cases, the vaccine is still recommended as a treatment in most instances, especially for older patients: \"The balance of benefits and known risks is still very favorable for the majority of people. But for younger age groups it was more finely balanced.\",  says Dr June Raine. Still, those complications have lead to a decrease in vaccination speed in several countries, which has benefited the spread of the often deadly virus further. This should lead to a serious conversation about how risks of health treatments are presented in a public discourse.", "task_condition": "viz", "task_key": "astrazeneca", "task_level": "post_graduate_ma_msc", "time_taken_in_seconds": 1903448}}}